Results 21 to 30 of about 1,111 (177)

N-acetylaspartate promotes glycolytic-to-oxidative fiber-type switch and resistance to atrophic stimuli in myotubes [PDF]

open access: yesCell Death and Disease
N-acetylaspartate (NAA) is a neuronal metabolite that can be extruded in extracellular fluids and whose blood concentration increases in several neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS).
Serena Castelli   +8 more
doaj   +2 more sources

Ablating the Transporter Sodium-Dependent Dicarboxylate Transporter 3 Prevents Leukodystrophy in Canavan Disease Mice. [PDF]

open access: yesAnn Neurol, 2021
Canavan disease is caused by ASPA mutations that diminish brain aspartoacylase activity, and it is characterized by excessive brain storage of the aspartoacylase substrate, N-acetyl-l-aspartate (NAA), and by astroglial and intramyelinic vacuolation ...
Wang Y   +7 more
europepmc   +2 more sources

Central Dysmyelination in SSADH-Deficient Humans and Mice. [PDF]

open access: yesAnn Clin Transl Neurol
ABSTRACT Objectives Succinic semialdehyde dehydrogenase deficiency (SSADHD) is an inherited metabolic disorder characterized by an accumulation of γ‐aminobutyric (GABA). In addition to its synaptic role as an inhibitory neurotransmitter, GABA also plays an important role in myelination.
Tokatly Latzer I   +11 more
europepmc   +2 more sources

Enhanced brain distribution of modified aspartoacylase [PDF]

open access: yesMolecular Genetics and Metabolism, 2014
Canavan disease is a fatal neurological disorder caused by defects in the gene that produces the enzyme aspartoacylase. Enzyme replacement therapy can potentially be used to overcome these defects if a stable enzyme form that can gain access to the appropriate neural cells can be produced.
Nitesh K, Poddar   +4 more
openaire   +2 more sources

Acetate Revisited: A Key Biomolecule at the Nexus of Metabolism, Epigenetics, and Oncogenesis – Part 2: Acetate and ACSS2 in Health and Disease

open access: yesFrontiers in Physiology, 2020
Acetate, the shortest chain fatty acid, has been implicated in providing health benefits whether it is derived from the diet or is generated from microbial fermentation of fiber in the gut.
John R. Moffett   +4 more
doaj   +1 more source

Acetate Revisited: A Key Biomolecule at the Nexus of Metabolism, Epigenetics and Oncogenesis—Part 1: Acetyl-CoA, Acetogenesis and Acyl-CoA Short-Chain Synthetases

open access: yesFrontiers in Physiology, 2020
Acetate is a major end product of bacterial fermentation of fiber in the gut. Acetate, whether derived from the diet or from fermentation in the colon, has been implicated in a range of health benefits.
John R. Moffett   +4 more
doaj   +1 more source

Mutational analysis of aspartoacylase: Implications for Canavan Disease [PDF]

open access: yesBrain Research, 2007
Mutations that result in near undetectable activity of aspartoacylase, which catalyzes the deacetylation of N-acetyl-l-aspartate, correlate with Canavan Disease, a neurodegenerative disorder usually fatal during childhood. The underlying biochemical mechanisms of how these mutations ablate activity are poorly understood.
Jeremy R, Hershfield   +3 more
openaire   +2 more sources

Combined transcriptome and proteome analyses reveal differences in the longissimus dorsi muscle between Kazakh cattle and Xinjiang brown cattle [PDF]

open access: yesAnimal Bioscience, 2021
Objective With the rapid development of proteomics sequencing and RNA sequencing technology, multi-omics analysis has become a current research hotspot.
XiangMin Yan   +9 more
doaj   +1 more source

Canavan Disease: Clinical and laboratory profile from Southern part of India

open access: yesAnnals of Indian Academy of Neurology, 2021
Background: Canavan disease (CD) is an autosomal recessively inherited leukodystrophy. It affects one in 6,400 to 13,500 people in the Jewish population.
Vykuntaraju K Gowda   +4 more
doaj   +1 more source

Brain Nat8l Knockdown Suppresses Spongiform Leukodystrophy in an Aspartoacylase-Deficient Canavan Disease Mouse Model [PDF]

open access: yes, 2018
Canavan disease, a leukodystrophy caused by loss-of-function ASPA mutations, is characterized by brain dysmyelination, vacuolation, and astrogliosis ("spongiform leukodystrophy").
Olga Chechneva   +19 more
core   +1 more source

Home - About - Disclaimer - Privacy